Author Archives: pancreatica
FOLFIRINOX Dose Modification Study
Pancreatic Cancer Blog – Commentary on Articles and AbstractsHere is where we take complex medical articles and break them down into language you and I can understand. Click Here for more Articles and Abstracts. FOLFIRINOX Dose Modification Study6/29/2023CLICK HERE for the original article or abstract ! A recent study titled “Real-world dose reduction of standard and […]
Mitazalimab receives orphan Status for pancreatic cancer
Mitazalimab is a monoclonal antibody that targets CD40, a protein that is expressed on the surface of many types of cancer cells. CD40 signaling is thought to play a role in tumor growth and metastasis. Mitazalimab works by blocking CD40 signaling, which can lead to tumor cell death. The FDA has granted orphan drug designation […]